6 resultados para GENERICS
em Repositório Institucional UNESP - Universidade Estadual Paulista "Julio de Mesquita Filho"
Resumo:
Comparative HPLC-UV and LC-MS/MS studies of impurity profiles of a reference sample (Xenical (R), F. Hoffmann La Roche Ltd., Switzerland) vs. generic (Lipiblock (R), EMS Sigma Pharma, a generic drug) were carried out with ethanol extracts of commercial samples. The generic formulation contained higher levels of common impurities as well as a considerable number of impurities not found in the reference product. The detected impurity profile of Lipiblock (R) revealed that it most likely is based on fermentation. Since the effect of the impurities is unknown, at this point fully synthetic Xenical (R) appears to offer a better safety margin than Lipiblock (R) which, however, compares quite well to other generic formulations.
Resumo:
In Brazil, the registration of new drugs is carried out only when the regulatory agency (Anvisa, acronym in Portuguese) is fully satisfied with the evidence of their quality, efficacy and safety, presented by a pharmaceutical industry that strive for this registration. With the patent expiration, pharmaceutical companies are attracted to produce biological medicines called biosimilar or biogenerics or simply generics, whose approval may result in reduced treatment costs. But it is necessary that the biosimilar be, at least, equally efective and safe and without contaminants in relation to the original. Recent consensus guidelines aim to establish criteria for efcacy and safety of these medicines. Preclinical studies in vitro and in vivo, the origin of raw materials and clinical studies phase I, II and III are recommended for biosimilar medicine registration in the international market. Low molecular weight heparins are found in this situation. In this review we specifcally addressed this type of medicine, which could serve as a benchmark for other biosimilar medicines.
Resumo:
Comparative HPLC-UV and LC-MS/MS studies of impurity profiles of a reference sample (Xenical®, F. Hoffmann-La Roche Ltd., Switzerland) vs. generic (Lipiblock®, EMS-Sigma Pharma, a generic drug) were carried out with ethanol extracts of commercial samples. The generic formulation contained higher levels of common impurities as well as a considerable number of impurities not found in the reference product. The detected impurity profile of Lipiblock® revealed that it most likely is based on fermentation. Since the effect of the impurities is unknown, at this point fully synthetic Xenical® appears to offer a better safety margin than Lipiblock® which, however, compares quite well to other generic formulations.
Resumo:
The objective of this study is to examine the pharmaceutical industry and changes that the fall of patents and entry of generics may cause in the price and consumption of drugs. Thus, there is a brief discussion about the global pharmaceutical industry, from its origins to the present day, showing in particular the case of the United States, today considered the largest industry in this sector. From this, the work seeks to address specifically the Brazilian industry and its regulation. Since the generic law implementation, the participation of this type of medicine has grown significantly in the country. Because they have always been lower than prices of their brand, the cost of treating disease is reduced, which makes generic drugs represent an improvement for consumers in terms of welfare of society
Resumo:
Atenolol is the most used drug in Brazil to hypertension treatment. Two crystal structures are known for this molecule: a racemic form (R,S)-atenolol and a pure form S-atenolol. The racemic form is found in commercial tablets. X-ray powder diffraction (XRD) is an adequate tool to study crystalline structures including drugs. Using the Rietveld Method with XRD data it is possible to quantify the crystalline structures existing in the raw material. Other methods like Le Bail and Pawley can be used to the profile fit and phases identification. For this work we analyzed three tablets of atenolol, two generics and the reference (materials were purchased from a drugstore at the city of Araraquara). These tablets were analyzed by Rietveld, Le Bail and Pawley methods. All tablets exhibited the racemic mixture API (R,S)-atenolol. Some crystalline excipients could be characterized: magnesium carbonate hydrate, lactose monohydrate and talc. The conclusion is that the three methods can be efficiently used to characterize the three atenolol tablets.
Resumo:
Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999